TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds October 31, 2003